{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:55:28Z","timestamp":1784606128225,"version":"3.55.0"},"reference-count":51,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2017SGR1480"],"award-info":[{"award-number":["2017SGR1480"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["Grant M-ERA-NET-3 \/ PCI2023-143431"],"award-info":[{"award-number":["Grant M-ERA-NET-3 \/ PCI2023-143431"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-107160RB-I00"],"award-info":[{"award-number":["PID2019-107160RB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-128891OB-I00"],"award-info":[{"award-number":["PID2021-128891OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","award":["SEC\/FEC-INV-TRL 20\/015"],"award-info":[{"award-number":["SEC\/FEC-INV-TRL 20\/015"]}],"id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Patients with diabetes are at an increased risk of diabetic cardiomyopathy (DCM) and acute myocardial infarction (AMI). Protecting the heart against AMI is more challenging in DCM than in nondiabetic hearts. We investigated whether intravenous (i.v.) atorvastatin administration during AMI exerts cardioprotection in DCM as seen in nondiabetic hearts. Sprague-Dawley rats were divided into streptozotocin-induced DCM and normoglycemic control groups. Our model of DCM rats exhibited interstitial fibrosis and cardiac dysfunction at 5 weeks. At this time point, all animals underwent AMI induction (coronary ligation for 45 min), receiving i.v. atorvastatin or vehicle during ischemia. Animals were reperfused and sacrificed 24 h later for myocardial infarct size analysis and cardiac tissue sampling. Echocardiography was performed. DCM vehicle rats had larger infarcts than normoglycemic vehicle-treated animals at a comparable area-at-risk. Intravenous atorvastatin reduced infarct size and preserved systolic function in both groups. Compared with vehicle animals, i.v. atorvastatin inhibited RhoA membrane translocation, induced AMPK phosphorylation, prevented apoptosis execution, and improved cardiac remodelling in the infarcted heart of both groups, whereas innate immune cell infiltration was further reduced in i.v. atorvastatin-treated DCM animals. The proven cardioprotective effectiveness of this i.v. statin formulation in the presence of DCM warrants its further development into a clinically therapeutic option.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>Diabetic cardiomyopathy (DCM) significantly increases the risk of acute myocardial infarction and attenuates or abolishes the cardioprotective effects of several therapeutic approaches. Whether intravenous atorvastatin administration during ongoing acute myocardial infarction retains its cardioprotective potential in the presence of DCM was investigated. Intravenous atorvastatin during ischemia reduces infarct size and preserves cardiac function in DCM rats. The efficacy of this intravenous statin formulation in DCM supports its development as a viable therapeutic option for clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db24-0510","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:31:06Z","timestamp":1741869066000},"page":"1021-1032","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":7,"title":["Cardioprotection During Myocardial Infarction in Diabetic Cardiomyopathy"],"prefix":"10.2337","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3699-1769","authenticated-orcid":false,"given":"Sebasti\u00e0","family":"Alcover","sequence":"first","affiliation":[{"name":"1Sant Pau Research Institute (IR SANT PAU), Barcelona, Spain"},{"name":"2Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1794-879X","authenticated-orcid":false,"given":"Sergi","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"1Sant Pau Research Institute (IR SANT PAU), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3512-8474","authenticated-orcid":false,"given":"Lisaidy","family":"Ramos-Regalado","sequence":"additional","affiliation":[{"name":"1Sant Pau Research Institute (IR SANT PAU), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2982-8982","authenticated-orcid":false,"given":"Nat\u00e0lia","family":"Mu\u00f1oz-Garc\u00eda","sequence":"additional","affiliation":[{"name":"1Sant Pau Research Institute (IR SANT PAU), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-2175","authenticated-orcid":false,"given":"Alex","family":"Gallinat","sequence":"additional","affiliation":[{"name":"1Sant Pau Research Institute (IR SANT PAU), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0193-3115","authenticated-orcid":false,"given":"Rosa","family":"Suades","sequence":"additional","affiliation":[{"name":"1Sant Pau Research Institute (IR SANT PAU), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-2459","authenticated-orcid":false,"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[{"name":"1Sant Pau Research Institute (IR SANT PAU), Barcelona, Spain"},{"name":"3CiberCV, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-8873","authenticated-orcid":false,"given":"Gemma","family":"Vilahur","sequence":"additional","affiliation":[{"name":"1Sant Pau Research Institute (IR SANT PAU), Barcelona, Spain"},{"name":"3CiberCV, Institute of Health Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"2026020215312720100_B1","first-page":"1130","article-title":"Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality","volume":"119","author":"Lezoualc'h"},{"key":"2026020215312720100_B2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2026020215312720100_B3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"2026020215312720100_B4","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1111\/bph.15294","article-title":"Risk factors, co-morbidities, and co-medications in cardioprotection: importance for translation","volume":"177","author":"Schulz","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2026020215312720100_B5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/ijms20030514","article-title":"Post-genomic methodologies and preclinical animal models: chances for the translation of cardioprotection to the clinic","volume":"20","author":"Badimon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026020215312720100_B6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/pharmrev.121.000348","article-title":"Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia\/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning","volume":"75","author":"Ferdinandy","year":"2023","journal-title":"Pharmacol Rev"},{"key":"2026020215312720100_B7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCRESAHA.118.313341","article-title":"Effect of intracoronary metformin on myocardial infarct size in swine","volume":"123","author":"Techiryan","year":"2018","journal-title":"Circ Res"},{"key":"2026020215312720100_B8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","article-title":"Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury","volume":"54","author":"Bose","year":"2005","journal-title":"Diabetes"},{"key":"2026020215312720100_B9","doi-asserted-by":"crossref","first-page":"1012220","DOI":"10.3389\/fcvm.2022.1012220","article-title":"In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study","volume":"9","author":"Cesaro","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026020215312720100_B10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10557-022-07360-w","article-title":"Effects of glucagon-like peptide-1 receptor agonist (GLP-1RA) on cardiac structure and function: a systematic review and meta-analysis of randomized-controlled trials","volume":"38","author":"Wong","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026020215312720100_B11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-019-0760-z","article-title":"Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia","volume":"115","author":"Mendieta","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"2026020215312720100_B12","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2020.01.042","article-title":"Intravenous statin administration during myocardial infarction compared with oral post-infarct administration","volume":"75","author":"Mendieta","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026020215312720100_B13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ Res"},{"key":"2026020215312720100_B14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijcard.2014.06.040","article-title":"HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model","volume":"175","author":"Vilahur","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026020215312720100_B15","article-title":"Prevention or reduction of ischemia-related damage","author":"Badimon","year":"2017"},{"key":"2026020215312720100_B16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/etm.2017.4457","article-title":"Pharmacological postconditioning with atorvastatin calcium attenuates myocardial ischemia\/reperfusion injury in diabetic rats by phosphorylating GSK3\u03b2","volume":"14","author":"Chen","year":"2017","journal-title":"Exp Ther Med"},{"key":"2026020215312720100_B17","doi-asserted-by":"crossref","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie Du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"2026020215312720100_B18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00395-018-0696-8","article-title":"Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection","volume":"113","author":"B\u00f8tker","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"2026020215312720100_B19","doi-asserted-by":"crossref","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","article-title":"Guidelines for experimental models of myocardial ischemia and infarction","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020215312720100_B20","doi-asserted-by":"crossref","first-page":"5.47.1","DOI":"10.1002\/0471141755.ph0547s70","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"70","author":"Furman","year":"2015","journal-title":"Curr Protoc Pharmacol"},{"key":"2026020215312720100_B21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1475-2840-12-133","article-title":"Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats","volume":"12","author":"Li","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"2026020215312720100_B22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0024-3205(01)01141-9","article-title":"Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model","volume":"69","author":"Mihm","year":"2001","journal-title":"Life Sci"},{"key":"2026020215312720100_B23","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0735-1097(99)00436-2","article-title":"Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway","volume":"34","author":"Joffe","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2026020215312720100_B24","doi-asserted-by":"crossref","first-page":"28886","DOI":"10.3402\/fnr.v59.28886","article-title":"Protective effects of L-arabinose in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats","volume":"59","author":"Hao","year":"2015","journal-title":"Food Nutr Res"},{"key":"2026020215312720100_B25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","article-title":"Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function","volume":"117","author":"Zacchigna","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2026020215312720100_B26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/CS20110176","article-title":"PKC\u03b2 inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes","volume":"122","author":"Liu","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"2026020215312720100_B27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1152\/japplphysiol.00862.2016","article-title":"Involvement of glycogen synthase kinase-3\u03b2 in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats","volume":"122","author":"Yang","year":"2017","journal-title":"J Appl Physiol (1985)"},{"key":"2026020215312720100_B28","doi-asserted-by":"crossref","first-page":"e22291","DOI":"10.1096\/fj.202101660RR","article-title":"Differential cholesterol uptake in liver cells : a role for PCSK9","volume":"36","author":"Luquero","year":"2022","journal-title":"FASEB J"},{"key":"2026020215312720100_B29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2021.01.036","article-title":"Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia\/reperfusion injury","volume":"165","author":"Dambrova","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"2026020215312720100_B30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bjp.0705097","article-title":"Myocardial ischaemia\/reperfusion injury and preconditioning: effects of hypercholesterolaemia\/hyperlipidaemia","volume":"138","author":"Ferdinandy","year":"2003","journal-title":"Br J Pharmacol"},{"key":"2026020215312720100_B31","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/ijms23073587","article-title":"Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus","volume":"23","author":"Nakamura","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026020215312720100_B32","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/15384101.2022.2139126","article-title":"Inhibition of farnesyl pyrophosphate synthase alleviates cardiomyopathy in diabetic rat","volume":"22","author":"Liu","year":"2023","journal-title":"Cell Cycle"},{"key":"2026020215312720100_B33","doi-asserted-by":"crossref","first-page":"e110446","DOI":"10.1371\/journal.pone.0110446","article-title":"Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice","volume":"9","author":"Noda","year":"2014","journal-title":"PLoS One"},{"key":"2026020215312720100_B34","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1111\/jcmm.15180","article-title":"Cardiac metabolism as a driver and therapeutic target of myocardial infarction","volume":"24","author":"Zuurbier","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2026020215312720100_B35","first-page":"1008","article-title":"Nutrient Excess in AMPK downregulation and insulin resistance","volume":"1","author":"Coughlan","year":"2015","journal-title":"J Endocrinol Diabetes Obes"},{"key":"2026020215312720100_B36","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","article-title":"AMPK, insulin resistance, and the metabolic syndrome","volume":"123","author":"Ruderman","year":"2013","journal-title":"J Clin Invest"},{"key":"2026020215312720100_B37","doi-asserted-by":"crossref","first-page":"112563","DOI":"10.1016\/j.biopha.2021.112563","article-title":"AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a pre-clinical and clinical investigation","volume":"146","author":"Entezari","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"2026020215312720100_B38","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4161\/auto.7.10.16740","article-title":"AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy","volume":"7","author":"Xie","year":"2011","journal-title":"Autophagy"},{"key":"2026020215312720100_B39","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ Res"},{"key":"2026020215312720100_B40","doi-asserted-by":"crossref","first-page":"e015298","DOI":"10.1161\/CIRCIMAGING.123.015298","article-title":"Cardioprotective effect of empagliflozin and circulating ketone bodies during acute myocardial infarction","volume":"16","author":"Santos-Gallego","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026020215312720100_B41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.yjmcc.2010.12.021","article-title":"Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction","volume":"50","author":"Vilahur","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"2026020215312720100_B42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/HJH.0000000000000826","article-title":"Increased myocardial vulnerability to ischemia-reperfusion injury in the presence of left ventricular hypertrophy","volume":"34","author":"M\u00f8lgaard","year":"2016","journal-title":"J Hypertens"},{"key":"2026020215312720100_B43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.atherosclerosis.2012.07.003","article-title":"Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction","volume":"224","author":"Vilahur","year":"2012","journal-title":"Atherosclerosis"},{"key":"2026020215312720100_B44","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/13813455.2020.1866017","article-title":"Diabetic cardiomyopathy attenuated the protective effect of ischaemic post-conditioning against ischaemia-reperfusion injury in the isolated rat heart model","volume":"129","author":"Kurian","year":"2023","journal-title":"Arch Physiol Biochem"},{"key":"2026020215312720100_B45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/cvr\/cvae264","article-title":"Cardioprotection exerted by intravenous statin at index myocardial infarction event attenuates cardiac damage upon recurrent infarction","volume":"121","author":"Vilahur","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026020215312720100_B46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fphys.2018.00453","article-title":"Diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures","volume":"9","author":"Toedebusch","year":"2018","journal-title":"Front Physiol"},{"key":"2026020215312720100_B47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/immuno2020021","article-title":"The immunomodulatory effects of statins on macrophages","volume":"2","author":"Sheridan","year":"2022","journal-title":"Immuno"},{"key":"2026020215312720100_B48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1464-5491.2008.02414.x","article-title":"Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing","volume":"25","author":"Muller","year":"2008","journal-title":"Diabet Med"},{"key":"2026020215312720100_B49","doi-asserted-by":"crossref","first-page":"1092015","DOI":"10.1155\/2017\/1092015","article-title":"Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats","volume":"2017","author":"Al-Rasheed","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"2026020215312720100_B50","doi-asserted-by":"crossref","first-page":"154543","DOI":"10.1016\/j.phymed.2022.154543","article-title":"Astragalus polysaccharides alleviates cardiac hypertrophy in diabetic cardiomyopathy via inhibiting the BMP10-mediated signaling pathway","volume":"109","author":"Sun","year":"2023","journal-title":"Phytomedicine"},{"key":"2026020215312720100_B51","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1002\/cpz1.78","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"1","author":"Furman","year":"2021","journal-title":"Curr Protoc"}],"updated-by":[{"DOI":"10.2337\/db26-er04a","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000}}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/74\/6\/1021\/801098\/db240510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/74\/6\/1021\/801098\/db240510.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:31:38Z","timestamp":1770064298000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/74\/6\/1021\/157977\/Cardioprotection-During-Myocardial-Infarction-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3,13]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db24-0510","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]}}}